Zydus Lifesciences Typhoid Vaccine Gets WHO Prequalification
By Rediff Money Desk, New Delhi Oct 23, 2024 11:22
Zydus Lifesciences's Typhoid Vi conjugate vaccine, ZyVac TCV, has received WHO prequalification, making it eligible for UN procurement. The vaccine is indicated for active immunisation against Salmonella typhi infection in individuals aged 6 months to 65 years.
New Delhi, Oct 23 (PTI) Zydus Lifesciences Ltd on Wednesday said it has received in-principle acceptability from the World Health Organisation for its Typhoid Vi conjugate vaccine, ZyVac TCV making it eligible for purchase by United Nations procurement agencies.
ZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad and is indicated for active immunisation against Salmonella typhi infection in the age group of 6 months to 65 years, Zydus Lifesciences said in a regulatory filing.
This prequalification for ZyVac TCV makes it eligible to be part of UN agencies' procurement programme.
"Annually over 150 million doses of the typhoid conjugate vaccine is procured by UN agencies to prevent this infectious disease in geographies where it is most prevalent, such as India, Africa and Southeast Asia," the company said.
In the South Asian region, India alone contributes 75 per cent of incidence and mortality due to typhoid fever, it added.
ZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad and is indicated for active immunisation against Salmonella typhi infection in the age group of 6 months to 65 years, Zydus Lifesciences said in a regulatory filing.
This prequalification for ZyVac TCV makes it eligible to be part of UN agencies' procurement programme.
"Annually over 150 million doses of the typhoid conjugate vaccine is procured by UN agencies to prevent this infectious disease in geographies where it is most prevalent, such as India, Africa and Southeast Asia," the company said.
In the South Asian region, India alone contributes 75 per cent of incidence and mortality due to typhoid fever, it added.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.99 (+ 1.52)
- 58018780
- Mishtann Foods L
- 9.17 ( -5.17)
- 27555831
- Shree Securities
- 0.42 ( -6.67)
- 27309223
- AvanceTechnologies
- 0.90 ( -4.26)
- 25537567
- Rajnish Wellness
- 1.69 ( -2.87)
- 19267607
MORE NEWS
Zepto Cuts Losses, Revenue Doubles in FY24
Quick commerce firm Zepto narrowed its losses to Rs 1,248.6 crore in FY24, while...
KKR Sells 2.6% Stake in India Grid Trust for Rs...
Private equity firm KKR has sold a 2.6% stake in India Grid Trust for Rs 277 crore...
MFN Clause Suspension: India Needs Strategic...
Switzerland's suspension of the MFN clause in its tax treaty with India highlights the...